Postapproval Comparative Safety Study of Tofacitinib and Biological Disease-Modifying Antirheumatic Drugs: 5-Year Results from a United States-Based Rheumatoid Arthritis Registry.

Kremer, Joel M; Bingham, Clifton O; Cappelli, Laura C; Greenberg, Jeffrey D; Madsen, Ann M; Geier, Jamie; Rivas, Jose L; Onofrei, Alina M; Barr, Christine J; Pappas, Dimitrios A; Litman, Heather J; Dandreo, Kimberly J; Shapiro, Andrea B; Connell, Carol A; Kavanaugh, Arthur

Kremer, Joel M; Bingham, Clifton O; Cappelli, Laura C; Greenberg, Jeffrey D; Madsen, Ann M; Geier, Jamie; Rivas, Jose L; Onofrei, Alina M; Barr, Christine J; Pappas, Dimitrios A; Litman, Heather J; Dandreo, Kimberly J; Shapiro, Andrea B; Connell, Carol A; Kavanaugh, Arthur.

Afiliação

Kremer JM; Albany Medical College, Center for Rheumatology, Albany, New York.
Bingham CO; Johns Hopkins University, Baltimore, Maryland.
Cappelli LC; Johns Hopkins University, Baltimore, Maryland.
Greenberg JD; Corrona, Waltham, Massachusetts, and New York University School of Medicine.
Madsen AM; Pfizer, New York, New York, USA.
Geier J; Pfizer, New York, New York, USA.
Rivas JL; Pfizer SLU, Madrid, Spain.
Onofrei AM; Corrona, Waltham, Massachusetts.
Barr CJ; Corrona, Waltham, Massachusetts.
Pappas DA; Corrona, Waltham, Massachusetts, and Columbia University, New York, New York.
Litman HJ; Corrona, Waltham, Massachusetts.
Dandreo KJ; Corrona, Waltham, Massachusetts.
Shapiro AB; Pfizer, Peapack, New Jersey.
Connell CA; Pfizer, Groton, Connecticut.
Kavanaugh A; University of California, San Diego School of Medicine, La Jolla.

ACR Open Rheumatol ; 3(3): 173-184, 2021 Mar.

Article em En | MEDLINE | ID: mdl-33570260

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ACR Open Rheumatol Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google